Literature DB >> 27234808

Psychosocial Aspects of Continuous Glucose Monitoring: Connecting to the Patients' Experience.

Thomas Kubiak1, Caroline G Mann2, Katherine C Barnard3, Lutz Heinemann4.   

Abstract

Continuous glucose monitoring (CGM) systems provide people with diabetes with valuable real-time information on glucose trajectories and trends, thus offering opportunities for improving diabetes self-management. Ample evidence from clinical trials underscores CGM effectiveness for biomedical outcomes including HbA1C and hypoglycemia. However, interindividual variability in CGM uptake seems to be substantial: Neither do all individuals with diabetes adopt CGM readily in their diabetes self-management, nor do all of them benefit from CGM. In this article, we focus on CGM effects on quality of life and the potential role of psychosocial patient characteristics for determining the uptake and outcomes of CGM. After providing a brief overview on existing evidence on psychosocial factors in CGM use, gaps in existing research are identified and directions for future research are proposed that could answer key research questions and offer guidance for clinical diabetes care.
© 2016 Diabetes Technology Society.

Entities:  

Keywords:  continuous glucose monitoring; patient-reported outcomes; psychological barriers; psychosocial issues

Mesh:

Substances:

Year:  2016        PMID: 27234808      PMCID: PMC4928243          DOI: 10.1177/1932296816651450

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  26 in total

1.  Psychosocial factors associated with use of continuous glucose monitoring.

Authors:  M D Ritholz; A Atakov-Castillo; M Beste; E A Beverly; A Leighton; K Weinger; H Wolpert
Journal:  Diabet Med       Date:  2010-09       Impact factor: 4.359

Review 2.  Is continuous glucose monitoring (CGM) for everyone? To whom should CGM be prescribed and how?

Authors:  J-P Riveline
Journal:  Diabetes Metab       Date:  2011-12       Impact factor: 6.041

3.  Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes.

Authors:  M Tansey; L Laffel; J Cheng; R Beck; J Coffey; E Huang; C Kollman; J Lawrence; J Lee; K Ruedy; W Tamborlane; T Wysocki; D Xing
Journal:  Diabet Med       Date:  2011-09       Impact factor: 4.359

4.  Health utilities for children and adults with type 1 diabetes.

Authors:  Joyce M Lee; Kirsten Rhee; Michael J O'grady; Anirban Basu; Aaron Winn; Priya John; David O Meltzer; Craig Kollman; Lori M Laffel; Jean M Lawrence; William V Tamborlane; Tim Wysocki; Dongyuan Xing; Elbert S Huang
Journal:  Med Care       Date:  2011-10       Impact factor: 2.983

5.  Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment.

Authors:  O Kordonouri; E Pankowska; B Rami; T Kapellen; R Coutant; R Hartmann; K Lange; M Knip; T Danne
Journal:  Diabetologia       Date:  2010-08-14       Impact factor: 10.122

6.  Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes.

Authors:  Tadej Battelino; Moshe Phillip; Natasa Bratina; Revital Nimri; Per Oskarsson; Jan Bolinder
Journal:  Diabetes Care       Date:  2011-02-19       Impact factor: 19.112

7.  Improving glycaemic control and life skills in adolescents with type 1 diabetes: a randomised, controlled intervention study using the Guided Self-Determination-Young method in triads of adolescents, parents and health care providers integrated into routine paediatric outpatient clinics.

Authors:  Gitte R Husted; Birger Thorsteinsson; Bente Appel Esbensen; Eva Hommel; Vibeke Zoffmann
Journal:  BMC Pediatr       Date:  2011-06-14       Impact factor: 2.125

8.  Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.

Authors:  John C Pickup; Suzanne C Freeman; Alex J Sutton
Journal:  BMJ       Date:  2011-07-07

9.  Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.

Authors: 
Journal:  Health Qual Life Outcomes       Date:  2006-10-11       Impact factor: 3.186

10.  Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial.

Authors: 
Journal:  Diabetes Care       Date:  2009-10-16       Impact factor: 19.112

View more
  8 in total

1.  Impact of Human Factors Testing on Medical Device Design: Validation of an Automated CGM Sensor Applicator.

Authors:  Robert North; Christine Pospisil; Ryan J Clukey; Christopher G Parkin
Journal:  J Diabetes Sci Technol       Date:  2019-02-14

2.  Development of a Novel Tool to Support Engagement With Continuous Glucose Monitoring Systems and Optimize Outcomes.

Authors:  Katharine D Barnard-Kelly; William H Polonsky
Journal:  J Diabetes Sci Technol       Date:  2019-05-21

Review 3.  Role of Continuous Glucose Monitoring in Clinical Trials: Recommendations on Reporting.

Authors:  Oliver Schnell; Katharine Barnard; Richard Bergenstal; Emanuele Bosi; Satish Garg; Bruno Guerci; Thomas Haak; Irl B Hirsch; Linong Ji; Shashank R Joshi; Maarten Kamp; Lori Laffel; Chantal Mathieu; William H Polonsky; Frank Snoek; Philip Home
Journal:  Diabetes Technol Ther       Date:  2017-05-22       Impact factor: 6.118

4.  Perceived Usefulness of Continuous Glucose Monitoring Devices at the Workplace: Secondary Analysis of Data From a Qualitative Study.

Authors:  Jessica Scharf; Xuan Quynh Nguyen; Patricia Vu-Eickmann; Michael Krichbaum; Adrian Loerbroks
Journal:  J Diabetes Sci Technol       Date:  2018-07-20

Review 5.  Barriers and Facilitators to Diabetes Device Adoption for People with Type 1 Diabetes.

Authors:  Molly L Tanenbaum; Persis V Commissariat
Journal:  Curr Diab Rep       Date:  2022-05-06       Impact factor: 5.430

6.  Use of continuous glucose monitoring for sport in type 1 diabetes.

Authors:  Alif Abdulrahman; Janisha Manhas; Hannah Linane; Mark Gurney; Catriona Fitzgerald; Esther O'Sullivan
Journal:  BMJ Open Sport Exerc Med       Date:  2018-12-17

Review 7.  Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners.

Authors:  Ramzi Ajjan; David Slattery; Eugene Wright
Journal:  Adv Ther       Date:  2019-01-18       Impact factor: 3.845

8.  Hypo-METRICS: Hypoglycaemia-MEasurement, ThResholds and ImpaCtS-A multi-country clinical study to define the optimal threshold and duration of sensor-detected hypoglycaemia that impact the experience of hypoglycaemia, quality of life and health economic outcomes: The study protocol.

Authors:  Patrick Divilly; Natalie Zaremba; Zeinab Mahmoudi; Uffe Søholm; Daniel J Pollard; Melanie Broadley; Evertine J Abbink; Bastiaan de Galan; Ulrik Pedersen-Bjergaard; Eric Renard; Mark Evans; Jane Speight; Alan Brennan; Rory J McCrimmon; Matthias Müllenborn; Simon Heller; Alexander Seibold; Julia K Mader; Stephanie A Amiel; Frans Pouwer; Pratik Choudhary
Journal:  Diabet Med       Date:  2022-06-22       Impact factor: 4.213

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.